Oncomine Myeloid Panel (MDS, MPN, AML, CML, CMML, JMML) in UAE | 5000 AED | 2026 DHA Guidelines

تحليل Oncomine Myeloid Panel في الإمارات | 5000 درهم | معتمد من هيئة الصحة بدبي

الملخص التنفيذي: فحص نخاع العظم المتطور بتقنية تسلسل الجيل التالي (NGS) لدقة تشخيصية بنسبة 99.9% وفق معايير الآيزو ومعتمد من هيئة الصحة بدبي، يشمل جميع الطفرات والاندماجات الجينية لأمراض النخاع النقوية (MDS، MPN، AML، CML، CMML، JMML). خدمة سحب منزلي متميزة، دعم طبي هاتفي بعد النتيجة، وتحقق فوري من التأمين عبر واتساب.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing.
Premium Logistics: Paid Hospital‑Grade Home Collection with ISO‑Certified Cold‑Chain Transport and VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance: Complimentary telephonic post‑test interpretation with a DHA‑licensed consultant.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 (no personal data shared).

Overview

The Oncomine Myeloid Panel is a comprehensive next‑generation sequencing assay that interrogates DNA and RNA to detect clinically relevant mutations, fusions, and gene expression profiles across all major myeloid malignancies—MDS, MPN, AML, CML, CMML, and JMML. (لوحة جينية متكاملة لتشخيص أمراض النخاع النقوية باستخدام تقنية التسلسل الجيني المتقدم.) In a single bone marrow or peripheral blood sample, it replaces multiple single‑gene tests and provides a complete molecular landscape within 2–3 weeks, empowering precise risk stratification and targeted therapy decisions.

Feature	Our Oncomine Myeloid Panel	Closest Alternative (Conventional Karyotyping & Single‑Gene PCR)
Precision	≥99.9% diagnostic sensitivity for 40+ genes and 29 fusion drivers	~60–70% detection rate; misses cryptic fusions and multiple mutations
Methodology	Next Generation Sequencing (DNA + RNA), ISO 9001:2015	Karyotyping, FISH, single‑gene Sanger sequencing
Turnaround Time	2–3 weeks	3–6 weeks (multiple sequential tests)

Physician Insight & Safety Protocol

Dr. Prabhakar Reddy (DHA License 61713011), Consultant Clinical Pathologist: “An NGS‑based myeloid panel often reveals variants of uncertain significance and requires careful clinico‑pathological correlation. I strongly advise that you discuss every finding with your hematologist before altering any treatment plan, because molecular results must be interpreted alongside blood counts, marrow morphology, and clinical symptoms.”

⚠️Medication Warning

Do not discontinue prescribed medication, including targeted therapy or supportive care, without consulting your doctor. Stopping treatment based solely on a new genetic finding can precipitate disease progression or blast crisis.

Exclusion Criteria & Emergency Red Flags

Bone marrow aspiration is contraindicated in patients with severe uncorrected coagulopathy or platelet count <20 × 10⁹/L without appropriate supportive measures.
For minors (under 18 years), the test requires signed parental/guardian consent in compliance with CDS Law 2026 and UAE child protection regulations.
Emergency Red Flags: If you experience persistent fever ≥38.5°C, uncontrolled bleeding, or sudden shortness of breath before the procedure, contact your physician immediately or proceed to the nearest emergency department. Do not delay for laboratory scheduling.

Patient FAQ & Clinical Guidance

1. Why is the Oncomine Myeloid Panel recommended over a single‑gene test?

This panel simultaneously interrogates 40+ genes and 29 fusion drivers in one NGS run, providing a complete molecular diagnosis in 2–3 weeks — eliminating the need for sequential single‑gene tests that delay treatment decisions. يقوم الفحص بتحليل أكثر من ٤٠ جيناً و٢٩ اندماجاً جينياً دفعة واحدة مما يغني عن الاختبارات المتتابعة ويُسرّع التشخيص الدقيق.

2. Is a bone marrow sample always required, and how painful is it?

Peripheral blood may be accepted for selected indications (e.g., monitoring); however, a bone marrow aspirate is the gold‑standard source for complete molecular profiling and is performed under local anesthesia with minimal discomfort. يمكن استخدام الدم المحيطي في بعض الحالات لكن نخاع العظم هو العينة المثالية ويتم سحبها تحت التخدير الموضعي بألم محدود.

3. How quickly will I get my results and who will explain them?

Your report is ready within 2–3 weeks, and our DHA‑licensed pathologist will provide a complimentary telephonic clinical interpretation session to guide the next steps. تصلك النتيجة خلال أسبوعين إلى ثلاثة أسابيع مع جلسة تفسير هاتفية مجانية من طبيب مرخص من هيئة الصحة بدبي.

Pre‑Test Instructions

A valid doctor’s prescription is required for all Oncomine Myeloid Panel orders, except for surgery clearance, pregnancy‑related testing, or pre‑travel health screening where a physician referral is not mandatory but recommended.
Sample: Bone Marrow (preferred) or Peripheral Blood (5 mL in EDTA tube). Fasting is not necessary.
Please inform the phlebotomist about any anticoagulant or antiplatelet medications prior to sample collection.
Home collection appointments: WhatsApp +971 54 548 8731 at least 6 hours in advance. Cold‑chain transport ensures sample integrity.

Legal: This is processed under Federal Decree‑Law No. 41 of 2024, UAE PDPL, and DHA standards. ISO 9001:2015 Cert: INT/EGQ/2509DA/3139. For insurance pre‑approval, contact our billing team.

دعم ثنائي اللغة متاح